MATINAS BIOPHARMA HLDGS INC's ticker is MTNB and the CUSIP is 576810105. A total of 1 filers reported holding MATINAS BIOPHARMA HLDGS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,074 | +111.0% | 46,722 | +484.4% | 0.00% | – |
Q2 2023 | $2,878 | +28680.0% | 7,995 | -62.4% | 0.00% | – |
Q1 2023 | $10 | +25.0% | 21,255 | +31.0% | 0.00% | – |
Q4 2022 | $8 | -99.9% | 16,231 | -16.1% | 0.00% | – |
Q3 2022 | $12,000 | +140.0% | 19,349 | +245.1% | 0.00% | – |
Q1 2022 | $5,000 | -91.7% | 5,607 | -87.8% | 0.00% | -100.0% |
Q3 2021 | $60,000 | -27.7% | 45,936 | -41.9% | 0.00% | +100.0% |
Q1 2021 | $83,000 | +730.0% | 79,023 | +965.9% | 0.00% | – |
Q4 2020 | $10,000 | – | 7,414 | +7314.0% | 0.00% | – |
Q3 2020 | $0 | – | 100 | 0.0% | 0.00% | – |
Q2 2020 | $0 | – | 100 | 0.0% | 0.00% | – |
Q1 2020 | $0 | -100.0% | 100 | -98.2% | 0.00% | – |
Q2 2018 | $2,000 | -92.0% | 5,529 | -73.9% | 0.00% | -100.0% |
Q4 2017 | $25,000 | – | 21,181 | +264662.5% | 0.00% | – |
Q3 2017 | $0 | -100.0% | 8 | -99.9% | 0.00% | -100.0% |
Q2 2017 | $22,000 | – | 13,260 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alliance Wealth Management Group | 400,826 | $465,000 | 0.23% |
Yellowstone Partners, LLC | 143,914 | $167,000 | 0.09% |
IFP Advisors, Inc | 251,172 | $291,000 | 0.01% |
HYMAN CHARLES D | 79,800 | $93,000 | 0.01% |
Virtu Financial LLC | 106,146 | $123,000 | 0.01% |
Raymond James Financial Services Advisors, Inc. | 659,890 | $765,000 | 0.01% |
Tower Research Capital LLC (TRC) | 21,181 | $25,000 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 189,000 | $219,000 | 0.00% |
BlackRock Inc. | 2,530,508 | $2,935,000 | 0.00% |
Bank of New York Mellon Corp | 175,325 | $203,000 | 0.00% |